US › Healthcare

Tempus AI, Inc. Class A Common Stock (TEM)

US · Healthcare · Health Information Services

$47.05+2.17%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$382.5M
Revenue YoY
+21.6%
Net profit
$5.6M
Profit YoY
+113.2%
EPS
$-0.35
EPS estimate
$-0.41
Net margin
1.5%

EPS came in at -0.35 against a street estimate of -0.41 — a beat of 14.6%.

Key statistics

Market cap
$7.92B
Forward P/E
0.0
P/B
17.79
Book value
$2.32
EPS (TTM)
$-1.44
52-week high
$104.32
52-week low
$40.77
50-day MA
$51.03
200-day MA
$59.40
Beta
3.46

Analyst view

Analysts rate Tempus AI, Inc. Class A Common Stock a buy (6 buy, 6 hold, 0 sell out of 12) with an average price target of $64.93.

Shareholding

Insiders
36.94%
Institutions
54.77%

Largest institutional holders

FundStake
ARK Investment Management LLC5.32%
BlackRock Inc4.97%
Baillie Gifford & Co Limited.4.79%
SoftBank Group Corp3.00%
JPMorgan Chase & Co2.73%
Vanguard Capital Management, LLC2.73%
Vanguard Portfolio Management, LLC2.59%
Amova Asset Management Americas, Inc2.40%

Recent filings & reports

DocumentDate
Quarterly report · Q2 20262026-07-30
Results announced · Q3 20262026-07-30
Material agreement · Q3 20262026-07-20
Reg FD disclosure · Q3 20262026-07-20
Shareholder vote results · Q2 20262026-05-22
Quarterly report · Q1 20262026-05-05
Proxy statement · Q2 20262026-04-07
Annual report FY20252026-02-24

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Tempus AI, Inc. Class A Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.